Abstract
Paediatric tuberculosis is often missed or overlooked due to non-specific symptoms and difficulties in diagnosis. Around 90% of the 205,000 children estimated to die from this disease every year are never treated. Our aim was to synthesize the available evidence on the efficacy and safety of different treatment regimens available for latent tuberculosis infection (LTBI) in children and adolescents.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
